Get the Stockscreener App
3.67
16.82%
-0.91
Cumberland Pharmaceuticals Inc stock is traded at $3.67, with a volume of 484.57K.
It is down -16.82% in the last 24 hours and down -3.30% over the past month.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
See More
Previous Close:
$4.58
Open:
$4.58
24h Volume:
484.57K
Relative Volume:
2.33
Market Cap:
$54.89M
Revenue:
$37.79M
Net Income/Loss:
$-10.38M
P/E Ratio:
-5.0274
EPS:
-0.73
Net Cash Flow:
$-1.00M
1W Performance:
-7.08%
1M Performance:
-3.30%
6M Performance:
+4.09%
1Y Performance:
-37.03%
1-Day Range:
$3.63
$4.58
1-Week Range:
$3.63
$5.03
52-Week Range:
$1.85
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Name
Cumberland Pharmaceuticals Inc
Sector
Phone
615-255-0068
Address
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.67 | 68.50M | 37.79M | -10.38M | -1.00M | -0.73 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 57.12B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
125.98 | 53.16B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.48 | 47.25B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.88 | 37.59B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
490.21 | 21.85B | 3.13B | 1.27B | 1.12B | 26.39 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-12-12 | Reiterated | UBS | Neutral |
| Feb-01-11 | Reiterated | UBS | Neutral |
| Dec-16-10 | Downgrade | UBS | Buy → Neutral |
| Aug-17-10 | Downgrade | Jefferies | Buy → Hold |
| Aug-17-10 | Reiterated | Morgan Joseph | Buy |
| Aug-17-10 | Reiterated | UBS | Buy |
| May-14-10 | Reiterated | Morgan Joseph | Buy |
View All
Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
CPIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cumberland: Fourth Quarter Financial Results Overview - Bitget
Earnings call transcript: Cumberland Pharmaceuticals Q4 2025 sees revenue surge - Investing.com
Cumberland Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Cumberland Pharmaceuticals 2025 revenue rises - TradingView
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PR Newswire
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - The Globe and Mail
Joint U.S. Commercialization of RedHill's Talicia® Commences - marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Cumberland Pharma schedules Mar. 3 call on 2025 results and company update - Stock Titan
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE - Yahoo Finance
Panic Selling: Will SCEPRG outperform during market ralliesJuly 2025 Catalysts & Weekly Breakout Watchlists - baoquankhu1.vn
Volume Report: Why is Cumberland Pharmaceuticals Inc stock going upWeekly Trend Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge - AOL.com
Merger Talk: Can Cumberland Pharmaceuticals Inc reach all time highs this yearPrice Action & Weekly Top Performers Watchlists - baoquankhu1.vn
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress - AOL.com
Dividend Watch: What is the dividend yield of Cumberland Pharmaceuticals IncWeekly Investment Report & Safe Capital Investment Plans - baoquankhu1.vn
Why is Cumberland Pharmaceuticals Inc. stock going upCPI Data & AI Enhanced Trading Signals - mfd.ru
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead - Intellectia AI
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Will Cumberland Pharmaceuticals Inc. announce a stock splitQuarterly Market Review & Accurate Trade Setup Notifications - mfd.ru
Momentum Shift: Is Cumberland Pharmaceuticals Inc stock a top performer YTDJuly 2025 Short Interest & Safe Entry Point Alerts - baoquankhu1.vn
Portfolio Shifts: What is the dividend yield of Cumberland Pharmaceuticals IncEarnings Risk Report & Capital Protection Trading Alerts - baoquankhu1.vn
What is the dividend yield of Cumberland Pharmaceuticals Inc.Quarterly Performance Summary & High Win Rate Trade Tips - mfd.ru
Why Cumberland Pharmaceuticals Inc. stock is favored by top institutionsRisk Management & Intraday High Probability Alerts - mfd.ru
Little Excitement Around Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Revenues As Shares Take 31% Pounding - simplywall.st
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200-Day Moving AverageHere's Why - MarketBeat
FDA fast tracks Dyscorban for treating heart problems in Duchenne - Muscular Dystrophy News
Ideas Watch: Why is Cumberland Pharmaceuticals Inc stock going upEarnings Miss & Long Hold Capital Preservation Tips - baoquankhu1.vn
FDA fast tracks Cumberland’s DMD heart disease therapy By Investing.com - Investing.com Nigeria
Cumberland Pharmaceuticals Wins Fast Track for Ifetroban - TipRanks
Cumberland Pharmaceuticals Receives FDA Fast Track Designation for DMD Therapy - TradingView
FDA fast tracks Cumberland’s DMD heart disease therapy - Investing.com
Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug - Investing.com Canada
Experimental Duchenne drug gets FDA fast track after 5.4% heart function gain - Stock Titan
Aug Chart Watch: Is Cumberland Pharmaceuticals Inc stock good for income investorsQuarterly Market Summary & High Return Trade Opportunity Guides - baoquankhu1.vn
Critical Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) vs. Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Stock Market Recap: Is Cumberland Pharmaceuticals Inc stock good for income investors2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Will Cumberland Pharmaceuticals Inc announce a stock splitJuly 2025 Price Swings & Reliable Price Breakout Alerts - baoquankhu1.vn
Breakout Watch: How does Cumberland Pharmaceuticals Inc score in quality rankings2025 Momentum Check & Real-Time Price Movement Reports - baoquankhu1.vn
Can Cumberland Pharmaceuticals Inc. reach all time highs this yearTrade Risk Assessment & Smart Swing Trading Alerts - Mfd.ru
Take Profit: Is Cumberland Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Levels & Fast Entry and Exit Trade Plans - mfd.ru
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Aug Reactions: Can SAMG lead its sector in growthQuarterly Trade Review & Daily Technical Forecast Reports - baoquankhu1.vn
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2025 Earnings Call Transcript - MSN
Cumberland Pharmaceuticals (NASDAQ:CPIX) shareholders are still up 67% over 1 year despite pulling back 10% in the past week - simplywall.st
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Pass Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
FOMO Trade: Is AVAV stock a good pick for beginnersJuly 2025 Rallies & Stock Portfolio Risk Management - baoquankhu1.vn
Targets Report: Can Cumberland Pharmaceuticals Inc beat the S P 5002025 Volume Leaders & Safe Capital Growth Stock Tips - baoquankhu1.vn
Cumberland Pharmaceuticals Inc Stock (CPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):